From diabetes care to migraine relief-GLP-1 therapy cuts monthly headache days and boosts daily function in chronic migraine patients with obesity.

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented today at...

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented today at...

MONDAY, June 30, 2025 -- Intermittent-fasting strategies yield small reductions in body weight compared with an ad libitum diet, according to a study...

WEDNESDAY, June 25, 2025 -- For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is...

WEDNESDAY, June 25, 2025 -- For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is...

Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing bchronic migraine in individuals with obesity. /b

TUESDAY, June 24, 2025 -- Self-esteem scores increase after metabolic and bariatric surgery (MBS), with greater improvement in scores for those with...

TUESDAY, June 24, 2025 -- Self-esteem scores increase after metabolic and bariatric surgery (MBS), with greater improvement in scores for those with...

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in adults with obesity, with...